The federal government is poised to remove marijuana from the most dangerous class of drugs, which could open up more clinical treatments and research opportunities. The Justice Department is recommending reclassifying marijuana as a Schedule III drug, down from a Schedule I drug. Its proposal, which would need to be cleared by the White House Office of Management and Budget, could allow researchers to investigate marijuana’s clinical applications more broadly.
Read the full article: What Marijuana Reclassification Could Mean for Health Treatments //
Source: https://www.modernhealthcare.com/providers/marijuana-reclassification-clinical-research